Indo Us Biotech Limited — Board Meeting, 26-05-2025: Outcome of Board Meeting

Indo-US Bio-Tech has announced a board meeting on 26 May 2025 to approve the financial results for the quarter and half-year. Revenue surged to Rs. 103.84 Cr from Rs. 72.84 Cr last year, boosting profit before tax to Rs. 16.53 Cr (up from Rs. 8.79 Cr). Net profit more than doubled to Rs. 16.27 Cr. Inventories increased to Rs. 70.69 Cr and equity rose to Rs. 78.52 Cr. Operational cash flow strengthened with net cash from operations at Rs. 19.53 Cr. No final dividend declared; interim dividend of Rs. 0.25/share paid earlier. Auditor's report came clean, indicating strong financial health.